Nanmo Biology: Director Wang Jinjing plans to reduce holdings by 0.0032%

robot
Abstract generation in progress
Nanmou Biology Announcement, as of the disclosure date of this announcement, Employee Representative Director Wang Jinjing directly holds 10,000 shares of the company, accounting for 0.0128% of the total share capital of the company, obtained from the unrestricted circulating shares acquired through the 2025 restricted stock incentive plan. Due to personal funding needs, she plans to reduce her holdings by no more than 2,500 shares through centralized bidding transactions, accounting for 0.0032% of the company's total share capital. The reduction period will be within three months after 15 trading days from the date of this announcement, specifically from June 25, 2026, to September 24, 2026. The reduction price will be determined based on the market price at the time of implementation.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned